This present study determined the clinicopathological significance of the α7-nAChR as a novel prognostic marker for patients with HCC, with a particular focus on probable associations with CSCs, macrometastasis, and survival. The gene discussed is CHRNA7; the disease is hepatocellular carcinoma.